{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:52:00Z","timestamp":1793479920903,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101609"],"award-info":[{"award-number":["82101609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A03J0436"],"award-info":[{"award-number":["2023A03J0436"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A03J0839"],"award-info":[{"award-number":["2023A03J0839"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0827"],"award-info":[{"award-number":["2023A03J0827"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013277","name":"National Clinical Key Specialty Project Foundation","doi-asserted-by":"publisher","award":["2023) 33"],"award-info":[{"award-number":["2023) 33"]}],"id":[{"id":"10.13039\/501100013277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["202206010077"],"award-info":[{"award-number":["202206010077"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011383"],"award-info":[{"award-number":["2023A1515011383"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012578"],"award-info":[{"award-number":["2024A1515012578"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jad.2025.03.041","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:06:01Z","timestamp":1741665961000},"page":"764-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Kynurenine pathway metabolites predict antianhedonic effects of electroconvulsive therapy in patients with treatment-resistant depression"],"prefix":"10.1016","volume":"379","author":[{"given":"Qing-Bin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Wei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Balbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.03.041_bb0005","article-title":"The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: a systematic review and meta-analysis","volume":"26","author":"Almulla","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.jad.2025.03.041_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193112","article-title":"The tryptophan catabolite or kynurenine pathway in a major depressive episode with melancholia, psychotic features and suicidal behaviors: a systematic review and meta-analysis","volume":"11","author":"Almulla","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jad.2025.03.041_bb0015","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.03.041_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders \u2014 (DSM-IV)","author":"Association, A.P","year":"1994"},{"key":"10.1016\/j.jad.2025.03.041_bb0025","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2022.2340","article-title":"The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: an overview","volume":"65","author":"Bartoli","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.03.041_bb0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/15622975.2023.2169348","article-title":"Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia","volume":"24","author":"Brum","year":"2023","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psychres.2007.05.010","article-title":"Implications of the DSM\u2019s emphasis on sadness and anhedonia in major depressive disorder","volume":"159","author":"Buckner","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.03.041_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2022.06.062","article-title":"Electroconvulsive therapy effects on anhedonia and reward circuitry anatomy: a dimensional structural neuroimaging approach","volume":"313","author":"Cano","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.03.041_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fpsyt.2019.00017","article-title":"The efficacy of vortioxetine on anhedonia in patients with major depressive disorder","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.03.041_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.euroneuro.2021.11.003","article-title":"Selective association of cytokine levels and kynurenine\/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression","volume":"55","author":"Comai","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.03.041_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158493","article-title":"Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways","volume":"23","author":"Correia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2025.03.041_bb0065","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.2018.17824","article-title":"The challenges of improving treatments for depression","volume":"320","author":"Cuijpers","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2025.03.041_bb0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/0269881111434622","article-title":"Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder","volume":"26","author":"Cutler","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.03.041_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2025.03.041_bb0080","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jad.2017.11.040","article-title":"A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls","volume":"227","author":"DeWitt","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.03.041_bb0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2025.03.041_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2006.08.020","article-title":"The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS)","volume":"99","author":"Franken","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.03.041_bb0095","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pnpbp.2009.09.015","article-title":"The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study","volume":"34","author":"Gabbay","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00702-011-0685-7","article-title":"The possible role of the kynurenine pathway in anhedonia in adolescents","volume":"119","author":"Gabbay","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jad.2025.03.041_bb0110","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1096\/fj.201900491RR","article-title":"Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice","volume":"33","author":"Gim\u00e9nez-G\u00f3mez","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jad.2025.03.041_bb0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","article-title":"The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway","volume":"48","author":"Guloksuz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.03.041_bb0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41386-020-0607-1","article-title":"Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression","volume":"45","author":"Haroon","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.03.041_bb0130","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression","volume":"29","author":"Hasler","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 6","key":"10.1016\/j.jad.2025.03.041_bb0135","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/brain\/116.6.1425","article-title":"A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate","volume":"116","author":"Heyes","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.jad.2025.03.041_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jat\/bkw071","article-title":"A simple HPLC-MS\/MS method for determination of tryptophan, kynurenine and kynurenic acid in human serum and its potential for monitoring antidepressant therapy","volume":"41","author":"Hu","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jad.2025.03.041_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/NDT.S296451","article-title":"Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder","volume":"17","author":"McIntyre","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.03.041_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.03.041_bb0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: a systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.03.041_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jad.2025.03.041_bb0175","first-page":"138","article-title":"The \u201chalf-age\u201d stimulation strategy for ECT dosing","volume":"12","author":"Petrides","year":"1996","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.jad.2025.03.041_bb0180","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0306-4522(92)90467-G","article-title":"Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse","volume":"51","author":"Saito","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2025.03.041_bb0190","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41598-020-58806-w","article-title":"Serum metabolic profiles of the tryptophan-kynurenine pathway in the high risk subjects of major depressive disorder","volume":"10","author":"Sakurai","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.03.041_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.03.041_bb0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","article-title":"Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients","volume":"13","author":"Schwieler","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2025.03.041_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/YCT.0b013e3182656e5d","article-title":"Age-based seizure threshold determination","volume":"29","author":"Swartz","year":"2013","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2025.03.041_bb0210","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4088\/JCP.v66n0803","article-title":"Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials","volume":"66","author":"Thase","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.03.041_bb0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroimage.2009.01.058","article-title":"The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques","volume":"46","author":"Wacker","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2025.03.041_bb0225","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5152\/alphapsychiatry.2023.231401","article-title":"Optimization strategies of transcranial magnetic stimulation in major depressive disorder","volume":"24","author":"Wen","year":"2023","journal-title":"Alpha Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0230","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jad.2024.09.038","article-title":"Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: a randomized, double-blind, controlled, non-inferiority trial","volume":"368","author":"Zeng","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.03.041_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110193","article-title":"Altered neural activity in the reward-related circuit and executive control network associated with amelioration of anhedonia in major depressive disorder by electroconvulsive therapy","volume":"109","author":"Zhang","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.03.041_bb0240","first-page":"238","article-title":"Reliability and validity of Hamilton Depression Scale assessed in 329 Chinese depression patients [in Chinese]","volume":"214\u2013216","author":"Zhao","year":"1992","journal-title":"Chin. Ment. Health J."},{"key":"10.1016\/j.jad.2025.03.041_bb0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2021.12.105","article-title":"Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression","volume":"300","author":"Zheng","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.03.041_bb0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13651501.2022.2138444","article-title":"Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions","volume":"27","author":"Zheng","year":"2023","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2025.03.041_bb0255","first-page":"85","article-title":"Reliability, validity and sensitivity of Montgomery-Asberg depression rating scale for patients with current major depression disorder [in Chinese]","volume":"20","author":"Zhong","year":"2011","journal-title":"Chin. J. Behav. Med. Brain Sci."},{"key":"10.1016\/j.jad.2025.03.041_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2018.09.007","article-title":"Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression","volume":"74","author":"Zhou","year":"2018","journal-title":"Brain Behav. Immun."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725003799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725003799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:36:11Z","timestamp":1777782971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725003799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S0165032725003799"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.03.041","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway metabolites predict antianhedonic effects of electroconvulsive therapy in patients with treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}